Latest Breaking News On - Biopharm division - Page 1 : comparemela.com

Vivani Medical Reports Second Quarter Financial Results and Provides Business Update

Vivani Medical, Inc. ; class= js-l-obf link link blue

United statesState of californiaBydureon bciseAdam mendelsohnExchange commissionDrug administrationVivani biopharm divisionCortigent incVivani medical incVivani medicalInvestigational new drugChief executiveRegistration statementBiopharm divisionAnticipated milestonesDate june

Vivani Medical Reports Second Quarter Financial Results and Provides Business Update

Vivani Medical Reports Second Quarter Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

State of californiaUnited statesAdam mendelsohnSean leousDonald dwyerBydureon bciseCompany contactCortigent incExchange commissionVivani medical incDrug administrationVivani biopharm divisionInvestigational new drugChief executiveRegistration statementBiopharm division

Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSean leousAdam mendelsohnBydureon bciseDon dwyerDevelopment expenseExchange commission theCompany contactCortigent incVivani medical incDrug administrationNeuromodulation divisionBiopharm divisionExchange commissionVivani neuromodulation divisionCommission on

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United statesBydureon bciseAdam mendelsohnExchange commission theDevelopment expenseCommission onCompany biopharm divisionBiopharm divisionExchange commissionVivani neuromodulation divisionVivani medical incDrug administrationNeuromodulation divisionCortigent incVivani medicalChief executive officer

Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants, including lead product candidate NPM-119 for the treatment of patients with type 2 diab.

United statesAdam mendelsohnBydureon bciseDevelopment expenseExchange commission theBiopharm divisionExchange commissionVivani neuromodulation divisionCompany biopharm divisionCommission onCortigent incVivani medical incDrug administrationNeuromodulation divisionVivani medicalChief executive officer